Dauricine

山豆根碱

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDauricine
Drug Alias NameNSC-36413
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThromboxane A2 receptor antagonistsVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channelThromboxane A2 receptor
Therapy Area/IndicationsMyocardial IschemiaArrhythmias, Cardiac
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesWuhan Medical College
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWuhan Medical College
Active IndicationsN/A
Inactive IndicationsMyocardial IschemiaArrhythmias, Cardiac

Other Information

ATC CodeN/A
Related LinksWikipedia